MetaCap

3M (MMM) vs West Pharmaceutical Services (WST)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

West Pharmaceutical Services (WST) has outperformed 3M (MMM) over the past year, gaining 37.8% versus a gain of 4.4%. Over five years, MMM leads with a +6.6% price change compared with -9.5% for WST. 3M is the larger company by market cap ($83.61 billion vs $25.79 billion), about 3.2 times the size, while West Pharmaceutical Services is growing revenue faster (+6.3% vs +1.5%).

On valuation, 3M trades at a lower forward P/E (16.5x vs 36.7x for West Pharmaceutical Services). 3M offers the higher dividend yield (1.86% vs 0.24%). West Pharmaceutical Services converts more of its revenue into profit, with a net margin of 16.1% versus 13.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MMM+4.37%WST+37.79%
+44%+14%-16%
Oct 7, 20251 yearOct 7, 2026
MMM+9.58%WST-9.99%
+27%-14%-55%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MMM versus WST key metrics
MetricMMMWST
Share price$162.12$366.48
Market cap$83.61B$25.79B
1-day change-0.93%-1.65%
YTD return+1.26%+33.20%
1-year return+4.37%+37.79%
5-year return+6.57%-9.47%
P/E ratio (TTM)28.8046.92
Forward P/E16.5036.72
EPS (TTM)$5.63$7.81
Dividend yield1.86%0.24%
Annual dividend$3.02$0.87
Revenue (latest FY)$24.95B$3.07B
Revenue growth (YoY)+1.52%+6.25%
Net income (latest FY)$3.25B$493.70M
Gross margin39.91%35.91%
Operating margin18.55%19.03%
Net margin13.03%16.06%
52-week high$184.90$386.00
52-week low$139.34$223.83
Distance from 52-week high-12.32%-5.06%
Analyst consensusbuystrong_buy
Avg. price target upside+15.51%+12.15%
Average volume3.16M629.98K
Shares outstanding515.72M70.38M
Employees60,50010,800
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • 3M is about 3.2 times larger than West Pharmaceutical Services by market value ($83.61B vs $25.79B).
  • WST has outperformed MMM by 33.4 percentage points over the past year.
  • West Pharmaceutical Services trades at a higher earnings multiple (46.9x vs 28.8x trailing P/E).
  • 3M offers a meaningfully higher dividend yield (1.86% vs 0.24%).

About 3M

MMM stock →

3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.

Health Care · Medical/Dental Instruments · 60,500 employees

About West Pharmaceutical Services

WST stock →

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Health Care · Medical/Dental Instruments · 10,800 employees

MMM vs WST FAQ

Which is bigger, 3M or West Pharmaceutical Services?

3M (MMM) is larger, with a market capitalization of $83.61B compared with $25.79B for West Pharmaceutical Services (WST).

Which stock has performed better over the past year, MMM or WST?

WST returned +37.79% over the past 12 months, compared with +4.37% for MMM (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, MMM or WST?

MMM has the lower trailing P/E at 28.8, versus 46.9 for WST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, 3M or West Pharmaceutical Services?

3M has the higher yield at 1.86%, compared with 0.24% for West Pharmaceutical Services.

Are 3M and West Pharmaceutical Services in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons